EUROPEAN BIOTECHS RAISE $2 BIL. IN FINANCING IN 1996, QUINTUPLING 1995 LEVEL; FRENCH, GERMAN BIOTECH HEATS UP ON HEELS OF MATURE U.K. INDUSTRY
Executive Summary
The amount of capital raised by the European biotechnology industry in 1996 grew four-fold over 1995 levels, Ernst & Young calculates in its fourth annual report on the European biotech industry. The report, entitled "European Biotech `97: A New Economy," was released April 22 at an Ernst & Young/Atlas Ventures life sciences conference in Amsterdam.